Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 4831 AL 4845

Recent advances in dopamine D(2) receptor ligands in the treatment of neuropsychiatric disorders

Juza R, Musilek K, Mezeiova E, Soukup O, Korabecny J.

Med Res Rev. 2023 Jan;43(1):55-211. doi: 10.1002/med.21923. Epub 2022 Sep 16.

LRRK2 phosphorylation of Rab GTPases in Parkinson's disease

Pfeffer SR.

FEBS Lett. 2023 Mar;597(6):811-818. doi: 10.1002/1873-3468.14492. Epub 2022 Sep 26.

Global Alterations of Whole Brain Structural Connectome in Parkinson's Disease: A Meta-analysis

Zuo C, Suo X, Lan H, Pan N, Wang S, Kemp GJ, Gong Q.

Neuropsychol Rev. 2023 Dec;33(4):783-802. doi: 10.1007/s11065-022-09559-y. Epub 2022 Sep 20.

Management of Motor Symptoms for Patients with Advanced Parkinson's Disease without Safe Oral Access: A Scoping Review

Kim W, Watt CL, Enright P, Sikora L, Zwicker J.

J Palliat Med. 2023 Jan;26(1):131-141. doi: 10.1089/jpm.2022.0193. Epub 2022 Sep 20.

The Therapeutic Potential of Salidroside for Parkinson's Disease

Li L, Yao W.

Planta Med. 2023 Apr;89(4):353-363. doi: 10.1055/a-1948-3179. Epub 2022 Sep 21.

Emerging roles of leptin in Parkinson's disease: Chronic inflammation, neuroprotection and more?

Regensburger M, Rasul Chaudhry S, Yasin H, Zhao Y, Stadlbauer A, Buchfelder M, Kinfe T.

Brain Behav Immun. 2023 Jan;107:53-61. doi: 10.1016/j.bbi.2022.09.010. Epub 2022 Sep 20.

Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease

Periñán MT, Macías-García D, Jesús S, Martín-Rodríguez JF, Muñoz-Delgado L, Jimenez-Jaraba MV, Buiza-Rueda D, Bonilla-Toribio M, Adarmes-Gómez AD, Gómez-Garre P, Mir P.

J Neurol. 2023 Jan;270(1):477-485. doi: 10.1007/s00415-022-11361-y. Epub 2022 Sep 28.

The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders

Alijanpour S, Miryounesi M, Ghafouri-Fard S.

Metab Brain Dis. 2023 Jan;38(1):1-16. doi: 10.1007/s11011-022-01091-5. Epub 2022 Sep 29.

Gut-oriented disease modifying therapy for Parkinson's disease

Lin CH, Lai HC, Wu MS.

J Formos Med Assoc. 2023 Jan;122(1):9-18. doi: 10.1016/j.jfma.2022.09.010. Epub 2022 Sep 29.

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

Jiao F, Zhou B, Meng L.

CNS Neurosci Ther. 2023 Jan;29(1):37-59. doi: 10.1111/cns.13985. Epub 2022 Oct 2.

Brain Energy Metabolism: Astrocytes in Neurodegenerative Diseases

Chen Z, Yuan Z, Yang S, Zhu Y, Xue M, Zhang J, Leng L.

CNS Neurosci Ther. 2023 Jan;29(1):24-36. doi: 10.1111/cns.13982. Epub 2022 Oct 3.

Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson's disease population: an open-label, levodopa add-on study

Belgian Safinamide Study Group; Bergmans B, Bourgeois P, Cras P, Dethy S, De Klippel N, Franco G, Garraux G, Geens K, Jacquerye P, Jeanjean A, Supiot F, Van der Linden C, Krygier C.

Acta Neurol Belg. 2023 Jun;123(3):939-947. doi: 10.1007/s13760-022-02100-1. Epub 2022 Oct 6.

Physical therapy interventions for the management of hand tremors in patients with Parkinson's disease: a systematic review

Shahien M, Elaraby A, Gamal M, Abdelazim E, Abdelazeem B, Ghaith HS, Negida A.

Neurol Sci. 2023 Feb;44(2):461-470. doi: 10.1007/s10072-022-06420-1. Epub 2022 Oct 7.

STN-DBS electrode placement accuracy and motor improvement in Parkinson's disease: systematic review and individual patient meta-analysis

Kremer NI, van Laar T, Lange SF, Statius Muller S, la Bastide-van Gemert S, Oterdoom DM, Drost G, van Dijk JMC.

J Neurol Neurosurg Psychiatry. 2023 Mar;94(3):236-244. doi: 10.1136/jnnp-2022-329192. Epub 2022 Oct 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias